These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 18356815)

  • 1. Therapeutic potential of genetically modified mesenchymal stem cells.
    Kumar S; Chanda D; Ponnazhagan S
    Gene Ther; 2008 May; 15(10):711-5. PubMed ID: 18356815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells: isolation, in vitro expansion and characterization.
    Beyer Nardi N; da Silva Meirelles L
    Handb Exp Pharmacol; 2006; (174):249-82. PubMed ID: 16370331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives.
    Abdallah BM; Kassem M
    J Cell Physiol; 2009 Jan; 218(1):9-12. PubMed ID: 18726996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human mesenchymal stem cells: from basic biology to clinical applications.
    Abdallah BM; Kassem M
    Gene Ther; 2008 Jan; 15(2):109-16. PubMed ID: 17989700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration.
    Kode JA; Mukherjee S; Joglekar MV; Hardikar AA
    Cytotherapy; 2009; 11(4):377-91. PubMed ID: 19568970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified mesenchymal stem cells and their clinical potential in acute cardiovascular disease.
    Griffin M; Greiser U; Barry F; O'Brien T; Ritter T
    Discov Med; 2010 Mar; 9(46):219-23. PubMed ID: 20350488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells.
    Väänänen HK
    Ann Med; 2005; 37(7):469-79. PubMed ID: 16278160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection and cardiac regeneration by mesenchymal stem cells.
    Schäfer R; Northoff H
    Panminerva Med; 2008 Mar; 50(1):31-9. PubMed ID: 18427386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
    Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K; Al-Ali H; Reinhardt A; Franke C; Hudecek M; Kamprad M; Tschiedel S; Cross M; Niederwieser D; Gentilini C
    Transplantation; 2009 Jan; 87(2):217-21. PubMed ID: 19155975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ; Atkinson K
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles.
    Hall B; Andreeff M; Marini F
    Handb Exp Pharmacol; 2007; (180):263-83. PubMed ID: 17554513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intervertebral disc regeneration in an ex vivo culture system using mesenchymal stem cells and platelet-rich plasma.
    Chen WH; Liu HY; Lo WC; Wu SC; Chi CH; Chang HY; Hsiao SH; Wu CH; Chiu WT; Chen BJ; Deng WP
    Biomaterials; 2009 Oct; 30(29):5523-33. PubMed ID: 19646749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic stem cells for cellular cardiomyoplasty: promises and premises.
    Walther G; Gekas J; Bertrand OF
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):917-24. PubMed ID: 19455667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
    Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
    Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE; Horibe E; Sacks J; Ikeguchi R; Breitinger J; Scozio M; Unadkat J; Feili-Hariri M
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
    Arinzeh TL
    Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesenchymal stromal cell contribution to homeostasis.
    Valtieri M; Sorrentino A
    J Cell Physiol; 2008 Nov; 217(2):296-300. PubMed ID: 18615579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.